Article
Unlocking the potential of RNA-based therapeutics in the lung: current status and future directions
23 Nov 2023
Abstract excerpt
Awareness of RNA-based therapies has increased after the widespread adoption of mRNA vaccines against SARS-CoV-2 during the COVID-19 pandemic. These mRNA vaccines had a significant impact on reducing lung disease and mortality. They highlighted the potential for rapid development of RNA-based therapies and advances in nanoparticle delivery systems. Along with the rapid advancement in RNA biology, including the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
